Towergate posts £5.5m ebitda loss for third quarter of 2015
Adjusted ebitda falls 50% for the three month period.
Towergate has reported a 10.3% fall in income for the third quarter of 2015.
The decline to £87m (Q3 2014: £97m) takes income for the year-to-date to £279.6m, a 9.7% fall on the first nine months of 2014.
With expenses growing to £74m for the quarter (Q3 2014: £70.9m) adjusted ebitda tumbled by 50% to £13m.
Once exceptional and group restructuring costs were added in the consolidator made an ebitda loss of £5.5m for the three month period of 2015 and of £18.7m for the year to date.
Divisional
The
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- Industry pays tribute to former colleague Geoff Kitchen, who died on Singapore Airlines flight
- Biba 2024: Work from home being used as a ‘bargaining chip’ in luring broker talent
- Biba 2024: Aviva not afraid of ‘tough’ conversations, but ‘categorially’ committed to broker PL, says MD Morris